Clinical Trial Update: Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 trial on personalizing treatment for pulmonary hypertension associated with diastolic heart failure was terminated; results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Heart Failure
• Heart Failure with Preserved Ejection Fraction
• Pulmonary Hypertension

Snippet

Sponsor: University of Florida | Conditions: Pulmonary Hypertension, Diastolic Heart Failure | Phase 4 | Status: TERMINATED | Results posted: 2022-02-10